Why is improving the diagnosis of skin cancer important? There are a number of different types of skin cancer. The most common is basal cell carcinoma (BCC). BCC is a localised cancer that can grow ...

Summary of dermoscopic features observed in basal cell carcinoma and their corresponding histopathological findings. The relationships presented are based on systematic reviews of dermoscopic and ...

Basal cell carcinoma is generally treated with invasive surgery to remove the tumor, which can cause pain, infection, bleeding and scarring. About Verrica Pharmaceuticals Inc. Verrica is a dermatology ...

The phase 3 study of Ameluz and RhodoLED photodynamic therapy for superficial basal cell carcinoma has reached a key milestone as the final patient has completed the 1-year follow-up visit.

Basal cell carcinoma, the most common type of skin cancer, accounts for about 80% of all skin cancers. Learn the types, symptoms, and treatments.

Learn more about targeted drug therapy, chemotherapy, surgery, and other options for treating advanced basal cell carcinoma.

Figure 2 In the primary analysis, the volcano plot indicates the causal relationship between metabolic traits and basal cell carcinoma, using the inverse-variance weighted method.

Kevin Jonas has become the latest celebrity to share news of a skin cancer diagnosis. The 36-year-old singer and actor took to Instagram to reveal he’d recently been diagnosed basal cell ...

A systematic analysis demonstrated the rarity of super-giant basal cell carcinomas and the need for further characterization of these understudied skin cancers.

Basal cell carcinomas often appear on the head, face, neck and arms. By Dani Blum Basal cell carcinoma is the most common form of skin cancer, but it can be easy to miss, or mistake for another ...

The phase 2 clinical trial of Verrica’s peptide-based immunotherapy trial for basal cell carcinoma has enrolled and dosed its final patient, the company announced in a press release. VP-315 ...

The label for sonidegib [is indicated for patients with] locally advanced basal cell carcinoma. These are daily drugs at the starting dose and [have several adverse events (AEs)] that many physicians ...